Medtronic’s Hugo surgical robot is making waves in the operating room. This new system aims to bring the benefits of ...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting Primary safety and effectiveness ...

Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...

Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...

Medtronic PLC (NYSE:MDT) released on Thursday results from the Enable Hernia Repair clinical study evaluating the performance of the Hugo robotic-assisted surgery (RAS) system in inguinal and ventral ...

The study aims to validate an integrated surgical ecosystem that combines robotics, imaging, instrumentation and workflow optimisation ...

Companies creating new robotic platforms marked additional milestones heading into the fourth quarter. Catch up with their progress in this roundup of the latest developments in surgical robotics.

Medtronic (NYSE:MDT) shares ticked up after the company met key effectiveness and safety goals in a study evaluating its Hugo robotic-assisted surgery system for inguinal and ventral hernia repairs.

DUBLIN and CHENNAI, India, Sept. 27, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with the Hugo™ ...

Medtronic plc (NYSE: MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S.